The role is accountable for developing ground-breaking therapies in Spinal Muscular Atrophy (SMA), Amyotrophic Lateral Sclerosis (ALS), and muscle diseases from early to late-stage clinical development.
Base: $194,000.00-$267,000.00; Bonus/Equity: Short-term cash bonus and long-term equity incentives available; Benefits: Medical, Dental, Vision, Life, 401(k) match, Tuition reimbursement
Must-have
Nice-to-have
Not specified